CATHY SINGER: Open Payments
NPI 1295214682 · SYOSSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,356 in 111 payments from 22 companies in 2025. Trend: 2023 $2,485 · 2024 $2,708 · 2025 $2,356
Food & beverage: $2,356
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $304 |
| ABBVIE INC. | 13 | $264 |
| Axsome Therapeutics, Inc. | 8 | $233 |
| Lilly USA, LLC | 11 | $227 |
| Amgen Inc. | 16 | $214 |
| Astellas Pharma US Inc | 9 | $194 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| GlaxoSmithKline, LLC. | 6 | $121 |
| Exact Sciences Corporation | 4 | $112 |
| Janssen Pharmaceuticals, Inc | 3 | $88 |
Products named: Veozah, Wegovy, OTEZLA, Auvelity, UBRELVY, VRAYLAR, FARXIGA, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
